Terms: = Head and neck cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Clinical Outcome
101 results:
1. Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival.
Zupancic M; Kostopoulou ON; Holzhauser S; Lukoseviciute M; Jylhä C; Marklund L; Näsman A; Sivars L; Dalianis T
Oral Oncol; 2024 Apr; 151():106749. PubMed ID: 38461771
[TBL] [Abstract] [Full Text] [Related]
2. Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.
Negrao MV; Araujo HA; Lamberti G; Cooper AJ; Akhave NS; Zhou T; Delasos L; Hicks JK; Aldea M; Minuti G; Hines J; Aredo JV; Dennis MJ; Chakrabarti T; Scott SC; Bironzo P; Scheffler M; Christopoulos P; Stenzinger A; Riess JW; Kim SY; Goldberg SB; Li M; Wang Q; Qing Y; Ni Y; Do MT; Lee R; Ricciuti B; Alessi JV; Wang J; Resuli B; Landi L; Tseng SC; Nishino M; Digumarthy SR; Rinsurongkawong W; Rinsurongkawong V; Vaporciyan AA; Blumenschein GR; Zhang J; Owen DH; Blakely CM; Mountzios G; Shu CA; Bestvina CM; Garassino MC; Marrone KA; Gray JE; Patel SP; Cummings AL; Wakelee HA; Wolf J; Scagliotti GV; Cappuzzo F; Barlesi F; Patil PD; Drusbosky L; Gibbons DL; Meric-Bernstam F; Lee JJ; Heymach JV; Hong DS; Heist RS; Awad MM; Skoulidis F
Cancer Discov; 2023 Jul; 13(7):1556-1571. PubMed ID: 37068173
[TBL] [Abstract] [Full Text] [Related]
3. A survival prediction model via interpretable machine learning for patients with oropharyngeal cancer following radiotherapy.
Pan X; Feng T; Liu C; Savjani RR; Chin RK; Sharon Qi X
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6813-6825. PubMed ID: 36807760
[TBL] [Abstract] [Full Text] [Related]
4. The Prognostic Significance of p16 and its Role as a Surrogate Marker for Human Papilloma Virus in Oral Squamous Cell Carcinoma: An Analysis of 281 Cases.
Doll C; Steffen C; Beck-Broichsitter B; Richter M; Neumann K; Pohrt A; Lohneis P; Lehmann A; Heiland M; Stromberger C; Coordes A; Johrens K; Raguse JD
Anticancer Res; 2022 May; 42(5):2405-2413. PubMed ID: 35489745
[TBL] [Abstract] [Full Text] [Related]
5. Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma.
Nannapaneni S; Griffith CC; Magliocca KR; Chen W; Lyu X; Chen Z; Wang D; Wang X; Shin DM; Chen ZG; Saba NF
PLoS One; 2021; 16(2):e0247498. PubMed ID: 33626078
[TBL] [Abstract] [Full Text] [Related]
6. An analysis of distant metastasis cases from HPV-associated oropharyngeal squamous cell carcinoma.
Brkic FF; Kadletz-Wanke L; Kenner L; Füreder T; Jank B; Brunner M; Heiduschka G
J Craniomaxillofac Surg; 2021 Apr; 49(4):312-316. PubMed ID: 33612410
[TBL] [Abstract] [Full Text] [Related]
7. Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224).
Saksø M; Mortensen LS; Primdahl H; Johansen J; Kallehauge J; Hansen CR; Overgaard J
Radiother Oncol; 2020 Oct; 151():126-133. PubMed ID: 32805273
[TBL] [Abstract] [Full Text] [Related]
8. PD-L1 Expression and a High Tumor Infiltrate of CD8+ Lymphocytes Predict outcome in Patients with Oropharyngeal Squamous Cells Carcinoma.
Wuerdemann N; Gültekin SE; Pütz K; Wittekindt C; Huebbers CU; Sharma SJ; Eckel H; Schubotz AB; Gattenlöhner S; Büttner R; Speel EJ; Klussmann JP; Wagner S; Quaas A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718057
[TBL] [Abstract] [Full Text] [Related]
9. p16 in highly malignant esophageal carcinomas: the correlation with clinicopathological factors and human papillomavirus infection.
Ishida H; Kasajima A; Fujishima F; Akaishi R; Ueki S; Yamazaki Y; Onodera Y; Gao X; Okamoto H; Taniyama Y; Kamei T; Sasano H
Virchows Arch; 2021 Feb; 478(2):219-229. PubMed ID: 32556556
[TBL] [Abstract] [Full Text] [Related]
10. The tumor immune microenvironment and its implications for clinical outcome in patients with oropharyngeal squamous cell carcinoma.
Gurin D; Slavik M; Hermanova M; Selingerova I; Kazda T; Hendrych M; Shatokhina T; Vesela M
J Oral Pathol Med; 2020 Oct; 49(9):886-896. PubMed ID: 32516834
[TBL] [Abstract] [Full Text] [Related]
11. Modulatory Role of Single Nucleotide Polymorphisms of Distinct Genetic Pathways on clinical Behavior of Medullary Thyroid Carcinoma.
Mishra V; Kowtal P; Rane P; Sarin R
Asian Pac J Cancer Prev; 2020 May; 21(5):1289-1293. PubMed ID: 32458635
[TBL] [Abstract] [Full Text] [Related]
12. Infiltrates of M2-Like Tumour-Associated Macrophages Are Adverse Prognostic Factor in Patients with Human Papillomavirus-Negative but Not in Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
Snietura M; Brewczynski A; Kopec A; Rutkowski T
Pathobiology; 2020; 87(2):75-86. PubMed ID: 32036360
[TBL] [Abstract] [Full Text] [Related]
13. HPV-positive Squamous Cell Carcinoma of the Larynx, Oral Cavity, and Hypopharynx: Clinicopathologic Characterization With Recognition of a Novel Warty Variant.
Rooper LM; Windon MJ; Hernandez T; Miles B; Ha PK; Ryan WR; Van Zante A; Eisele DW; D'Souza G; Fakhry C; Westra WH
Am J Surg Pathol; 2020 May; 44(5):691-702. PubMed ID: 31934915
[TBL] [Abstract] [Full Text] [Related]
14. HPV circulating tumoral DNA quantification by droplet-based digital PCR: A promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
Veyer D; Wack M; Mandavit M; Garrigou S; Hans S; Bonfils P; Tartour E; Bélec L; Wang-Renault SF; Laurent-Puig P; Mirghani H; Rance B; Taly V; Badoual C; Péré H
Int J Cancer; 2020 Aug; 147(4):1222-1227. PubMed ID: 31756275
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic significance of MTOR expression in HPV positive and negative head and neck cancers treated by chemoradiation.
Wilson TG; Hanna A; Recknagel J; Pruetz BL; Baschnagel AM; Wilson GD
Head Neck; 2020 Feb; 42(2):153-162. PubMed ID: 31657099
[TBL] [Abstract] [Full Text] [Related]
16. Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy in patients with head and neck squamous cell carcinoma.
Bunbanjerdsuk S; Vorasan N; Saethang T; Pongrujikorn T; Pangpunyakulchai D; Mongkonsiri N; Arsa L; Thokanit N; Pongsapich W; Anekpuritanang T; Ngamphaiboon N; Jinawath A; Sunpaweravong S; Pisitkun T; Suktitipat B; Jinawath N
Mod Pathol; 2019 Jul; 32(7):943-956. PubMed ID: 30737471
[TBL] [Abstract] [Full Text] [Related]
17. Dysregulation of ß-catenin, WISP1 and TCF21 predicts disease-specific survival and primary response against radio(chemo)therapy in patients with locally advanced squamous cell carcinomas of the head and neck.
Vyskocil E; Pammer J; Altorjai G; Grasl MC; Parzefall T; Haymerle G; Janik S; Perisanidis C; Erovic BM
Clin Otolaryngol; 2019 May; 44(3):263-272. PubMed ID: 30615266
[TBL] [Abstract] [Full Text] [Related]
18. Evolving role of human papillomavirus as a clinically significant biomarker in head and neck squamous cell carcinoma.
McMullen C; Chung CH; Hernandez-Prera JC
Expert Rev Mol Diagn; 2019 Jan; 19(1):63-70. PubMed ID: 30575409
[No Abstract] [Full Text] [Related]
19. Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.
Zhang X; Yang X; Zhu S; Li Q; Zou N
Oncol Rep; 2019 Mar; 41(3):1960-1970. PubMed ID: 30569171
[TBL] [Abstract] [Full Text] [Related]
20. Cytopathologic characteristics of HPV-related small cell carcinoma of the oropharynx.
Allison DB; Rooper LM; Mustafa S; Maleki Z; Wakely PE; Ali SZ
Cancer Cytopathol; 2019 Feb; 127(1):35-43. PubMed ID: 30468701
[TBL] [Abstract] [Full Text] [Related]
[Next]